Skip to main content
. 2018 Jan 16;2018(1):CD006847. doi: 10.1002/14651858.CD006847.pub2

Dai 2013.

Methods Design: parallel‐group
Randomisation: yes, method not stated
Blinding: open‐label
Withdrawals: stated
Participants Setting: single‐centre study, hospital outpatient department
Number eligible: 46
Number enrolled: 46
Number in treatment group: 23
Number in control group: 23
Number of withdrawals (treatment/control): 0/0
Number completing trial (treatment/control): 23/23
Age range: (treatment/control): 41 to 74years/47 to 72 years
Sex: 29 M, 17 F
Ethnicity: East Asian
NSCLC diagnosis: histologic or pathologically proven diagnosis of nonsquamous NSCLC, stage IIIB to IV disease
Inclusion criteria: age 18 to 75 years, Received prior platinum‐based chemotherapy of 4 to 6 cycles and has had progressive disease,at least 1 target lesion, ECOG 0 to 2, adequate bone marrow and organ function
Exclusion criteria: not stated
Baseline characteristics of treatment/control groups: comparable
Interventions Gefitinib 250 mg/day
Pemetrexed 500 mg/m2 intravenously, every 4 weeks until disease progression or unacceptable toxicity
Outcomes Tumour response – RECIST
Progression‐free survival
Overall survival
Toxicity – CTCAE
Quality of life – FACT‐L
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "randomized" but random sequence generation not discussed
Comment: there was insufficient information to permit a clear judgement of risk of bias
Allocation concealment (selection bias) Unclear risk No information provided
Comment: there was insufficient information to permit a clear judgement of risk of bias
Blinding (performance bias and detection bias) 
 All outcomes Low risk No blinding but review authors judge that outcome is not likely to be influenced by lack of blinding
Comment: this was judged as low risk of bias
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No missing data
Comment: this was judged as low risk of bias
Selective reporting (reporting bias) Low risk All prespecified outcomes were reported
Comment: this was judged as low risk of bias
Other bias Unclear risk No information provided
Comment: there was insufficient information to permit a clear judgement of risk of bias